Home> Products> seizmet sr 850 glycemic control

{ "products": [ { "_id": "66619067161afa2274ff4f3b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Metformin SR 850mg", "description": "SEIZMET SR 850 \nMetformin SR (850mg) \nIntroduction to SEIZMET SR 850\nSEIZMET SR 850 contains Metformin Hydrochloride 850mg in a sustained-release (SR) formulation. This medication is primarily used for the management of type 2 diabetes mellitus. Metformin belongs to a class of drugs known as biguanides, which help control blood sugar levels by improving the body's response to insulin. The sustained-release formulation ensures a prolonged effect throughout the day, providing steady glycemic control.\n\nWhat is Metformin?\nOverview of Metformin\nMetformin is an oral diabetes medication that helps lower blood sugar levels by improving insulin sensitivity and reducing glucose production in the liver. It also enhances glucose uptake and utilization in peripheral tissues, making it an effective treatment for type 2 diabetes.\n\nMechanism of Action\nInsulin Sensitization: Metformin works by decreasing hepatic glucose production and increasing insulin sensitivity in peripheral tissues, allowing cells to absorb glucose more effectively.\nGlucose Uptake: By enhancing insulin sensitivity, Metformin helps muscles and adipose tissues take up glucose from the bloodstream, lowering blood sugar levels.\nReduced Glucose Production: Metformin decreases the amount of glucose produced by the liver, contributing to overall glycemic control.\nBenefits of SEIZMET SR 850\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: SEIZMET SR 850 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting both insulin sensitivity and hepatic glucose production, Metformin provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET SR 850 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET SR 850 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Neutral or Loss: Unlike some other diabetes medications, Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nCardiovascular Benefits: Metformin has been shown to have beneficial effects on cardiovascular health, reducing the risk of heart disease and stroke in patients with type 2 diabetes.\nHow to Use SEIZMET SR 850\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET SR 850 is one tablet taken once daily with the evening meal. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET SR 850 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-sr-850-133444", "price": 43.0, "discountamount": 13.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "cells", "class", "Order", "EMAIL", "drugs", "water", "meals", "liver", "amount", "Action", "stroke", "option", "Support", "muscles", "readings", "Overview", "biguanides", "full glass", "one tablet", "neuropathy", "overweight", "Guidelines", "bloodstream", "utilization", "information", "retinopathy", "Optimal Use", "Adjustments", "Metformin SR", "Introduction", "sterispharma", "Reduced Risk", "best results", "evening meal", "sterisonline", "heart disease", "CALL/WHATSAPP", "SEIZMET SR 850", "glucose uptake", "Consistent Use", "Administration", "Weight Neutral", "obese patients", "typical dosage", "treatment plan", "unique mechanism", "Exercise Adjunct", "prolonged effect", "excellent adjunct", "Recommended Dosage", "modest weight loss", "peripheral tissues", "beneficial effects", "blood sugar control", "individual response", "Diabetes Management", "effective treatment", "healthcare provider", "insulin sensitivity", "cardiovascular health", "Insulin Sensitization", "cardiovascular disease", "Metformin Hydrochloride", "steady glycemic control", "Cardiovascular Benefits", "long-term complications", "lifestyle modifications", "type 2 diabetes mellitus", "overall glycemic control", "oral diabetes medication", "stable blood sugar levels", "Reduced Glucose Production", "Additional Health Benefits", "hepatic glucose production", "other diabetes medications", "gastrointestinal discomfort", "sustained-release formulation", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "sustained-release (SR) formulation", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1451, "imageuri": "https://productimages.withfloats.com/actual/66619068c06ee12d88cfeb92.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/66619068c06ee12d88cfeb92.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:33:11.434Z", "updatedon": "2026-03-13T06:30:27.801Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/metformin-sr-850mg/1451", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET SR 850 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET SR 850", "Metformin SR (850mg)", "Glycomet 850 SR in pregnancy", "Glycomet SR 850 composition", "Glycomet SR 850 side effects", "Metformin 850 mg price", "Glycomet 850 SR uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "696e129c1d5e7fc4677fb603", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "metformin hydrochloride 850 mg and Glimepiride 2 mg", "description": "Diabetes mellitus is one of the most common chronic lifestyle disorders worldwide, affecting millions of people and requiring long-term management. Type 2 diabetes, in particular, occurs when the body either does not produce enough insulin or cannot use insulin effectively. To manage this condition successfully, combination therapy is often recommended when a single medicine is not sufficient to control blood sugar levels.\n\nMetformin Hydrochloride 850 mg and Glimepiride 2 mg Tablets, marketed under the brand name SEIZMET G2 850, is a well-established and effective oral anti-diabetic combination. It is designed to control blood glucose levels through dual action, addressing both insulin resistance and inadequate insulin secretion.\n\nWhat is SEIZMET G2 850?\n\nSEIZMET G2 850 is a combination of two powerful anti-diabetic agents:\n\nMetformin Hydrochloride 850 mg\n\nGlimepiride 2 mg\n\nThis combination is widely prescribed for adults with Type 2 diabetes mellitus when diet, exercise, and monotherapy do not provide adequate glycemic control. By combining two complementary mechanisms, SEIZMET G2 850 helps achieve better and more stable blood sugar management.\n\nUses of Metformin Hydrochloride 850 mg and Glimepiride 2 mg Tablets\n\nThe primary use of SEIZMET G2 850 is the management of Type 2 diabetes mellitus. It is prescribed to:\n\nLower elevated blood glucose levels\n\nImprove insulin sensitivity\n\nEnhance insulin secretion from the pancreas\n\nPrevent diabetes-related complications\n\nThis medicine is especially beneficial for patients who experience persistent high blood sugar despite lifestyle modifications or single-drug therapy.\n\nHow SEIZMET G2 850 Works\n\nSEIZMET G2 850 works through a dual-action mechanism, ensuring effective blood sugar control throughout the day.\n\nRole of Metformin Hydrochloride\n\nMetformin primarily works by:\n\nReducing glucose production in the liver\n\nImproving insulin sensitivity in muscle and fat tissues\n\nDecreasing glucose absorption from the intestine\n\nIt does not cause excessive insulin release, which makes it less likely to cause hypoglycemia when used alone.\n\nRole of Glimepiride\n\nGlimepiride belongs to the sulfonylurea class and works by:\n\nStimulating the pancreas to release insulin\n\nImproving the body’s response to insulin\n\nLowering post-meal blood sugar spikes\n\nTogether, these actions make SEIZMET G2 850 a comprehensive and balanced treatment option for diabetes control.\n\nKey Benefits of SEIZMET G2 850\n\nSEIZMET G2 850 offers several important benefits for patients with Type 2 diabetes:\n\n1. Effective Blood Sugar Control\n\nThe combination ensures both fasting and post-prandial glucose levels remain within the target range.\n\n2. Dual Mechanism for Better Results\n\nBy addressing insulin resistance and insulin deficiency simultaneously, it provides superior glycemic control compared to single-drug therapy.\n\n3. Reduces Risk of Diabetes Complications\n\nProper blood sugar control helps reduce the risk of complications such as nerve damage, kidney disease, eye problems, and cardiovascular disorders.\n\n4. Improves Quality of Life\n\nStable glucose levels lead to better energy levels, improved well-being, and fewer diabetes-related symptoms.\n\n5. Convenient Combination Therapy\n\nCombining two medicines in one tablet improves patient compliance and simplifies daily medication routines.\n\nDosage and Administration\n\nThe dosage of SEIZMET G2 850 should be determined by a healthcare professional based on:\n\nBlood glucose levels\n\nAge and body weight\n\nKidney and liver function\n\nIndividual response to treatment\n\nThe tablet is usually taken once or twice daily with meals to reduce the risk of stomach upset and hypoglycemia. Patients should take the medicine at the same time each day for best results.\n\nIt is important to follow dietary advice, regular exercise, and blood glucose monitoring alongside medication.\n\nPossible Side Effects of SEIZMET G2 850\n\nLike all medicines, Metformin Hydrochloride 850 mg and Glimepiride 2 mg Tablets may cause side effects in some individuals.\n\nCommon Side Effects\n\nNausea\n\nDiarrhea\n\nAbdominal discomfort\n\nHeadache\n\nDizziness\n\nThese side effects are usually mild and temporary and often improve as the body adjusts to the medication.\n\nLess Common but Serious Side Effects\n\nHypoglycemia (low blood sugar), especially if meals are skipped\n\nLactic acidosis (rare but serious, associated with metformin)\n\nAllergic reactions such as skin rash or itching\n\nLiver function abnormalities\n\nPatients should seek medical attention if they experience symptoms such as excessive sweating, confusion, extreme weakness, breathing difficulty, or persistent stomach pain.\n\nPrecautions and Warnings\n\nSEIZMET G2 850 should be used only under medical supervision.\n\nPatients with kidney, liver, or heart disease should inform their doctor before use.\n\nAlcohol consumption should be avoided, as it may increase the risk of side effects.\n\nPregnant and breastfeeding women should consult their doctor before taking this medicine.\n\nRegular monitoring of blood sugar levels is essential to avoid hypoglycemia or uncontrolled diabetes.\n\nWho Should Use SEIZMET G2 850?\n\nSEIZMET G2 850 is suitable for:\n\nAdults diagnosed with Type 2 diabetes\n\nPatients inadequately controlled on metformin or glimepiride alone\n\nIndividuals requiring combination therapy for better glycemic control\n\nIt is not recommended for Type 1 diabetes or diabetic ketoacidosis.\n\nConclusion\n\nMetformin Hydrochloride 850 mg and Glimepiride 2 mg Tablets (SEIZMET G2 850) is a trusted and effective combination therapy for the management of Type 2 diabetes mellitus. By combining the benefits of metformin and glimepiride, it offers comprehensive blood sugar control, reduces the risk of long-term complications, and improves overall quality of life.", "price": 102.0, "discountamount": 30.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2280, "imageuri": "https://productimages.withfloats.com/actual/696e12d9cb45a8390116f1bf.png", "tileimageuri": "https://productimages.withfloats.com/tile/696e12d9cb45a8390116f1bf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-19T11:16:44.772Z", "updatedon": "2026-03-13T11:01:31.908Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metformin-hydrochloride-850-mg-and-glimepiride-2-mg/2280", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET G2 850", "category": "DIABETIC RANGE", "tags": [ "metformin hydrochloride 850 mg and glimepiride 2 mg tablets", "metformin 850 mg glimepiride 2 mg combination tablet", "glimepiride 2 mg with metformin 850 mg tablets", "metformin glimepiride fixed dose combination tablets", "metformin 850 mg glimepiride 2 mg dosage", "metformin glimepiride tablets for type 2 diabetes", "metformin and glimepiride tablets uses in diabetes", "metformin 850 mg glimepiride 2 mg for blood sugar control", "metformin glimepiride tablets mechanism of action", "metformin glimepiride tablets benefits", "metformin 850 mg glimepiride 2 mg side effects", "metformin glimepiride tablets precautions", "glimepiride metformin tablets safety in diabetes", "metformin glimepiride tablets contraindications", "metformin glimepiride tablets warnings", "metformin glimepiride tablets dosage guidelines", "how to take metformin 850 mg and glimepiride 2 mg tablets", "metformin glimepiride tablets before or after food", "metformin glimepiride tablets daily dose", "metformin glimepiride tablets price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662b5587de2b5203089e01d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE M 850 ", "description": "VILDIABATE M 850 \nMetformin (850mg)SR, Vildagliptin (50mg)\nIntroduction to VILDIABATE M 850\nVILDIABATE M 850 is a combination medication designed to manage type 2 diabetes mellitus effectively. It combines Metformin Hydrochloride Sustained Release (SR) 850mg and Vildagliptin 50mg. This dual-action formulation targets different pathways involved in glucose regulation, providing comprehensive blood sugar control. It is used alongside diet and exercise to improve glycemic control in adults with type 2 diabetes.\n\nKey Components and Their Mechanisms\nMetformin SR 850mg\nMetformin is a biguanide that helps lower blood sugar levels through several mechanisms:\n\nReduces Hepatic Glucose Production: Metformin decreases the amount of glucose produced by the liver.\nImproves Insulin Sensitivity: It enhances the sensitivity of muscle cells to insulin, promoting better glucose uptake and utilization.\nDecreases Intestinal Absorption of Glucose: Metformin reduces the absorption of glucose from the gastrointestinal tract.\nThe sustained-release (SR) formulation ensures a gradual release of the medication, providing prolonged therapeutic effects and reducing the risk of gastrointestinal side effects.\n\nVildagliptin 50mg\nVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by:\n\nEnhancing Incretin Levels: Vildagliptin inhibits the DPP-4 enzyme, which degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones increase insulin secretion and decrease glucagon release in a glucose-dependent manner.\nImproving Postprandial Glucose Control: By enhancing the action of incretin hormones, Vildagliptin helps regulate blood sugar levels after meals.\nBenefits of VILDIABATE M 850\nComprehensive Blood Sugar Control\nFasting and Postprandial Glucose Management: The combination of Metformin SR and Vildagliptin effectively manages both fasting and postprandial (after-meal) blood sugar levels.\nImproved Insulin Sensitivity and Secretion: Metformin improves insulin sensitivity, while Vildagliptin enhances insulin secretion in response to meals.\nExtended Release Formulation\nProlonged Effect: The sustained-release formulation of Metformin ensures a steady release of the medication, providing long-lasting blood sugar control and minimizing peaks and troughs in blood sugar levels.\nReduced Gastrointestinal Side Effects: The gradual release of Metformin helps reduce common gastrointestinal side effects associated with immediate-release formulations.\nAdditional Health Benefits\nLow Risk of Hypoglycemia: Vildagliptin has a low risk of causing hypoglycemia (low blood sugar) because it enhances insulin secretion only when blood glucose levels are elevated.\nWeight Neutral: This combination is generally weight-neutral, making it a suitable option for patients concerned about weight gain.\nDosage and Administration\nRecommended Dosage\nDosage: The typical dosage is one tablet taken once or twice daily, preferably with a meal to reduce gastrointestinal side effects.\nAdministration: Swallow the tablet whole with a glass of water. Do not crush, chew, or split the tablet unless advised by your healthcare provider.\nGuidelines for Optimal Use\nConsistent Use: For best results, take VILDIABATE M 850 regularly at the same time each day as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-m-850-133455", "price": 299.0, "discountamount": 89.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "diet", "Order", "EMAIL", "water", "glass", "liver", "GLP-1", "peaks", "meals", "adults", "amount", "option", "troughs", "Fasting", "exercise", "Low Risk", "patients", "readings", "response", "Enhancing", "same time", "biguanide", "Guidelines", "one tablet", "weight gain", "Optimal Use", "information", "Adjustments", "utilization", "Vildagliptin", "Metformin SR", "sterispharma", "Hypoglycemia", "Introduction", "best results", "sterisonline", "DPP-4 enzyme", "muscle cells", "CALL/WHATSAPP", "treatment plan", "glucose uptake", "steady release", "typical dosage", "Key Components", "Administration", "Weight Neutral", "Consistent Use", "low blood sugar", "Incretin Levels", "gradual release", "glycemic control", "VILDIABATE M 850", "glucagon release", "Prolonged Effect", "DPP-4) inhibitor", "incretin hormones", "insulin secretion", "glucose regulation", "several mechanisms", "different pathways", "Regular monitoring", "healthcare provider", "Insulin Sensitivity", "blood glucose levels", "Intestinal Absorption", "combination medication", "dipeptidyl peptidase-4", "gastrointestinal tract", "dual-action formulation", "meal) blood sugar levels", "type 2 diabetes mellitus", "glucose-dependent manner", "Recommended Dosage Dosage", "Additional Health Benefits", "Hepatic Glucose Production", "Extended Release Formulation", "sustained-release formulation", "prolonged therapeutic effects", "immediate-release formulations", "Postprandial Glucose Management", "long-lasting blood sugar control", "comprehensive blood sugar control", "sustained-release (SR) formulation", "common gastrointestinal side effects", "Reduced Gastrointestinal Side Effects", "Improving Postprandial Glucose Control", "glucose-dependent insulinotropic peptide", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1504, "imageuri": "https://productimages.withfloats.com/actual/667d44a2576e8da931df856b.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d44a2576e8da931df856b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T07:23:04.367Z", "updatedon": "2026-03-14T06:50:04.324Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//vildiabate-m-850-/1504", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE M 850 ", "category": "DIABETIC RANGE", "tags": [ "vildagliptin metformin 50/850 price", "vildagliptin and metformin hydrochloride tablets s" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a1d7da71f450faabc228b8d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "gliclazide sr 60mg and Dapagliflozin 10mg tablet", "description": "Managing Type 2 diabetes requires a comprehensive approach that helps control blood sugar levels while reducing the risk of long-term complications. The Gliclazide and Dapagliflozin combination is a modern and effective treatment option prescribed by healthcare professionals to improve glycemic control in adults with Type 2 diabetes mellitus. This combination works through two different mechanisms to help maintain healthy blood glucose levels, making it a preferred choice for patients who need better diabetes management.\n\nIf you are looking for a reliable diabetes treatment option, understanding the benefits, uses, and working mechanism of the Gliclazide and Dapagliflozin combination can help you make an informed decision in consultation with your healthcare provider.\n\nWhat is Gliclazide and Dapagliflozin Combination?\n\nThe Gliclazide and Dapagliflozin combination is an oral anti-diabetic medication used to control blood sugar levels in patients with Type 2 diabetes. It combines two powerful medicines:\n\nGliclazide – A sulfonylurea that stimulates the pancreas to release more insulin.\nDapagliflozin – An SGLT2 inhibitor that helps the kidneys remove excess glucose through urine.\n\nTogether, these medicines provide dual-action blood sugar control and help patients achieve better glycemic targets when diet, exercise, and single-drug therapy are insufficient.\n\nHow Does Gliclazide and Dapagliflozin Combination Work?\n\nThe effectiveness of this combination lies in its complementary mechanisms of action.\n\nGliclazide Action\n\nGliclazide works by stimulating the beta cells in the pancreas to produce and release more insulin. Increased insulin production helps transport glucose from the bloodstream into body cells, where it is used for energy.\n\nDapagliflozin Action\n\nDapagliflozin blocks the Sodium-Glucose Co-Transporter 2 (SGLT2) protein in the kidneys. This action reduces glucose reabsorption and allows excess sugar to be eliminated through urine, lowering blood glucose levels.\n\nCombined Benefits\n\nWhen used together, Gliclazide and Dapagliflozin help:\n\nReduce fasting blood sugar levels\nLower post-meal glucose spikes\nImprove HbA1c levels\nSupport long-term diabetes management\nProvide complementary glucose-lowering effects\nUses of Gliclazide and Dapagliflozin Combination\n\nHealthcare professionals commonly prescribe this combination for:\n\nType 2 Diabetes Mellitus\n\nThe primary use of the Gliclazide and Dapagliflozin combination is the treatment of Type 2 diabetes in adults whose blood sugar levels are not adequately controlled by lifestyle modifications alone.\n\nImproved Glycemic Control\n\nThis medication helps patients achieve better glycemic control and maintain stable blood glucose levels throughout the day.\n\nCombination Diabetes Therapy\n\nIt is often recommended when monotherapy with a single anti-diabetic medication fails to provide satisfactory results.\n\nLong-Term Diabetes Management\n\nThe combination can be used as part of a comprehensive diabetes management plan that includes healthy eating, exercise, and regular monitoring.\n\nBenefits of Gliclazide and Dapagliflozin Combination\n1. Dual Mechanism of Action\n\nThe combination attacks high blood sugar from two different angles, resulting in more effective glucose control.\n\n2. Better HbA1c Reduction\n\nPatients often experience significant reductions in HbA1c levels compared to treatment with a single medication.\n\n3. Effective Fasting and Postprandial Control\n\nThe medicine helps manage both fasting blood glucose and post-meal sugar spikes.\n\n4. Convenient Treatment Option\n\nCombining two medications into one treatment regimen can improve patient compliance and simplify diabetes management.\n\n5. Supports Weight Management\n\nUnlike some traditional diabetes medications, Dapagliflozin may contribute to modest weight reduction due to the elimination of excess glucose through urine.\n\n6. Cardiovascular Benefits\n\nDapagliflozin has been associated with cardiovascular benefits in certain patients, making it an attractive option for individuals with Type 2 diabetes and cardiovascular risk factors.\n\n7. Reduced Risk of Diabetes Complications\n\nMaintaining better blood sugar control may help reduce the risk of complications affecting the eyes, kidneys, nerves, and cardiovascular system.\n\nWhy Choose Gliclazide and Dapagliflozin Combination?\n\nThe growing popularity of this combination therapy stems from its ability to provide comprehensive blood sugar management. Physicians often recommend it because:\n\nIt targets multiple pathways involved in glucose regulation.\nIt provides strong glycemic control.\nIt helps reduce HbA1c effectively.\nIt offers potential weight-related benefits.\nIt supports long-term diabetes care goals.\n\nPatients seeking improved diabetes control often find this combination beneficial when prescribed and monitored by a healthcare professional.\n\nRecommended Dosage\n\nThe dosage of the Gliclazide and Dapagliflozin combination should always be determined by a healthcare provider based on:\n\nAge\nBlood glucose levels\nHbA1c values\nMedical history\nKidney function\nResponse to treatment\n\nPatients should take the medication exactly as prescribed and should not alter the dosage without medical advice.\n\nPrecautions Before Using Gliclazide and Dapagliflozin Combination\n\nBefore starting treatment, inform your doctor if you have:\n\nKidney disease\nLiver disorders\nHeart conditions\nFrequent urinary tract infections\nHistory of diabetic ketoacidosis\nSevere dehydration\nLow blood pressure\n\nPregnant and breastfeeding women should consult their healthcare provider before using this medication.\n\nPossible Side Effects\n\nLike all medications, the Gliclazide and Dapagliflozin combination may cause side effects in some individuals.\n\nCommon Side Effects\nIncreased urination\nThirst\nHeadache\nDizziness\nFatigue\nMild gastrointestinal discomfort\nHypoglycemia Symptoms\n\nSince Gliclazide stimulates insulin release, some patients may experience low blood sugar, especially when meals are skipped.\n\nSymptoms may include:\n\nSweating\nHunger\nTrembling\nWeakness\nConfusion\nRapid heartbeat\nUrinary and Genital Infections\n\nDapagliflozin increases glucose excretion through urine, which may increase the likelihood of:\n\nUrinary tract infections\nGenital fungal infections\n\nPrompt medical attention should be sought if symptoms occur.\n\nLifestyle Tips for Better Diabetes Control\n\nFor optimal results with the Gliclazide and Dapagliflozin combination, patients should follow a healthy lifestyle.\n\nMaintain a Balanced Diet\n\nFocus on:\n\nWhole grains\nVegetables\nFruits in moderation\nLean proteins\nHealthy fats\n\nAvoid excessive consumption of sugary foods and beverages.\n\nExercise Regularly\n\nPhysical activity helps improve insulin sensitivity and supports blood sugar control. Aim for at least 150 minutes of moderate exercise per week, as advised by your healthcare provider.\n\nMonitor Blood Sugar\n\nRegular blood glucose monitoring helps track treatment effectiveness and allows timely adjustments when necessary.\n\nStay Hydrated\n\nBecause Dapagliflozin increases urinary glucose excretion, adequate hydration is important to prevent dehydration.\n\nAttend Regular Checkups\n\nRoutine medical visits help monitor:\n\nHbA1c levels\nKidney function\nBlood pressure\nOverall diabetes control\nWho Can Benefit from Gliclazide and Dapagliflozin Combination?\n\nThis combination may be suitable for:\n\nAdults with Type 2 diabetes\nPatients requiring stronger glucose control\nIndividuals not achieving targets with single-drug therapy\nPatients seeking a dual-action diabetes treatment approach\nIndividuals requiring comprehensive glycemic management under medical supervision\nConclusion\n\nThe Gliclazide and Dapagliflozin combination is an advanced and effective treatment option for adults with Type 2 diabetes mellitus. By combining the insulin-stimulating action of Gliclazide with the glucose-eliminating benefits of Dapagliflozin, this therapy provides comprehensive blood sugar control and supports long-term diabetes management goals.\n\nWith benefits such as improved HbA1c reduction, fasting and post-meal glucose control, convenient therapy, and potential cardiovascular advantages, this combination has become an important choice in modern diabetes care. When used alongside a healthy diet, regular exercise, and proper medical supervision, the Gliclazide and Dapagliflozin combination can help patients achieve better glycemic control and improve their overall quality of life.", "price": 470.0, "discountamount": 141.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2433, "imageuri": "https://productimages.withfloats.com/actual/6a1d7da92f2aa2676dd01915.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a1d7da92f2aa2676dd01915.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-01T12:40:07.196Z", "updatedon": "2026-06-04T07:19:16.331Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gliclazide-sr-60mg-and-dapagliflozin-10mg-tablet/2433", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Gliclaglaze DAPA 60-10", "category": "DIABETIC RANGE", "tags": [ "gliclazide and dapagliflozin combination", "gliclazide sr 60mg and Dapagliflozin 10mg tablet", "gliclazide and dapagliflozin", "gliclazide and dapagliflozin together", "gliclazide dapagliflozin", "Gliclazide SR 60 mg and Dapagliflozin 10 mg Tablets", "Buy Gliclazide SR 60 mg Dapagliflozin 10 mg Tablets Online", "Type 2 Diabetes Treatment Tablets", "Gliclazide and Dapagliflozin Diabetes Medicine", "Gliclazide SR 60 mg Dapagliflozin 10 mg Product Image", "Best Tablets for Type 2 Diabetes Management", "Blood Sugar Control Tablets Gliclazide Dapagliflozin", "Gliclazide SR and Dapagliflozin Combination Tablets", "Diabetes Management Medicine Gliclazide Dapagliflozin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666191664515df1748621e0b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride 2mg, Metformin SR 500mg, Voglibose 0.2mg", "description": "SEIZMET TRIO 0.2 \nGlimepiride (2mg), Metformin SR (500mg), Voglibose (0.2mg)\nIntroduction to SEIZMET TRIO 0.2\nSEIZMET TRIO 0.2 is a combination medication that includes Glimepiride 2mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Voglibose 0.2mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Voglibose, SEIZMET TRIO 0.2 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Voglibose?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Voglibose\nVoglibose is an alpha-glucosidase inhibitor that helps control blood sugar levels by slowing the digestion and absorption of carbohydrates in the small intestine. This leads to a slower and lower rise in blood glucose levels after meals.\n\nBenefits of SEIZMET TRIO 0.2\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Voglibose slows carbohydrate absorption. This comprehensive approach offers robust glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET TRIO 0.2 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET TRIO 0.2 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nImproved Glycemic Control: Voglibose’s action on slowing carbohydrate absorption leads to better control over postprandial spikes, contributing to overall glycemic stability.\nHow to Use SEIZMET TRIO 0.2\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET TRIO 0.2 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Voglibose. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET TRIO 0.2 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-trio-0-2-133445", "price": 155.9, "discountamount": 46.77, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "Diet", "body", "liver", "meals", "water", "Order", "EMAIL", "option", "amount", "slower", "Action", "Support", "readings", "Overview", "pancreas", "Improved", "Voglibose", "digestion", "biguanide", "neuropathy", "full glass", "lower rise", "overweight", "one tablet", "Guidelines", "information", "Adjustments", "retinopathy", "utilization", "Optimal Use", "Metformin SR", "best results", "Introduction", "SEIZMET TRIO", "sterisonline", "Reduced Risk", "instructions", "sterispharma", "sulfonylurea", "effectiveness", "CALL/WHATSAPP", "carbohydrates", "Administration", "obese patients", "typical dosage", "treatment plan", "Consistent Use", "Glimepiride 2mg", "small intestine", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "excellent adjunct", "Weight Management", "weight neutrality", "insulin secretion", "Recommended Dosage", "modest weight loss", "blood sugar control", "Diabetes Management", "individual response", "postprandial spikes", "healthcare provider", "insulin sensitivity", "blood glucose levels", "pancreatic beta cells", "cardiovascular disease", "combination medication", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "robust glycemic control", "lifestyle modifications", "carbohydrate absorption", "type 2 diabetes mellitus", "complementary mechanisms", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "overall glycemic stability", "alpha-glucosidase inhibitor", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1452, "imageuri": "https://productimages.withfloats.com/actual/6661916a8e77bb2c7156e563.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661916a8e77bb2c7156e563.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:37:26.597Z", "updatedon": "2026-03-13T06:31:35.361Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-2mg-metformin-sr-500mg-voglibose-0-2mg/1452", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET TRIO 0.2 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET TRIO 0.2", "Glimepiride (2mg)", "Metformin SR (500mg)", "Voglibose (0.2mg)", "Glimepiride 2mg side effects", "glimepiride + metformin", "Glimepiride 2mg price", "Glimepiride 2mg Uses in Hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66618121a743fd2358220c35", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET GP 1 ", "description": "SEIZMET GP 1 \nGlimepiride (1mg), Metformin SR (500mg), Pioglitazone (15mg)\nIntroduction to SEIZMET GP 1\nSEIZMET GP 1 is a combination medication that includes Glimepiride 1mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Pioglitazone 15mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Pioglitazone, SEIZMET GP 1 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Pioglitazone?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that helps improve blood sugar control by increasing the body's sensitivity to insulin. It works by activating PPARγ (peroxisome proliferator-activated receptor gamma) receptors, which regulate the transcription of insulin-responsive genes involved in the control of glucose and lipid metabolism.\n\nBenefits of SEIZMET GP 1\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Pioglitazone enhances insulin sensitivity in peripheral tissues, providing a comprehensive approach to glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET GP 1 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET GP 1 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLipid Profile Improvement: Pioglitazone can improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, offering additional cardiovascular benefits.\nHow to Use SEIZMET GP 1\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET GP 1 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Pioglitazone. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET GP 1 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-gp-1-133442", "price": 144.45, "discountamount": 43.34, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "TZD", "body", "Diet", "Order", "EMAIL", "liver", "PPARγ", "water", "meals", "amount", "Action", "option", "Support", "pancreas", "Overview", "readings", "biguanide", "neuropathy", "one tablet", "full glass", "Guidelines", "overweight", "Optimal Use", "information", "utilization", "Adjustments", "retinopathy", "Metformin SR", "SEIZMET GP 1", "best results", "Pioglitazone", "Introduction", "sterisonline", "Reduced Risk", "Postprandial", "instructions", "sterispharma", "sulfonylurea", "triglycerides", "effectiveness", "CALL/WHATSAPP", "transcription", "Administration", "obese patients", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glimepiride 1mg", "lipid metabolism", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "weight neutrality", "thiazolidinedione", "excellent adjunct", "Weight Management", "insulin secretion", "peripheral tissues", "modest weight loss", "Recommended Dosage", "healthcare provider", "individual response", "blood sugar control", "insulin sensitivity", "Diabetes Management", "pancreatic beta cells", "HDL cholesterol levels", "combination medication", "cardiovascular disease", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "lifestyle modifications", "complementary mechanisms", "insulin-responsive genes", "type 2 diabetes mellitus", "Lipid Profile Improvement", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "additional cardiovascular benefits", "Metformin Hydrochloride Sustained Release", "peroxisome proliferator-activated receptor gamma) receptors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1440, "imageuri": "https://productimages.withfloats.com/actual/66618124c40ee9be019ac7b4.png", "tileimageuri": "https://productimages.withfloats.com/tile/66618124c40ee9be019ac7b4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T09:28:01.365Z", "updatedon": "2026-03-13T06:28:25.432Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//seizmet-gp-1-/1440", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET GP 1 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET GP 1", "Glimepiride (1mg)", "Metformin SR (500mg)", "Pioglitazone (15mg)", "Pioglitazone side effects", "Pioglitazone 15 mg price", "Pioglitazone uses", "Pioglitazone 30 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666174c62bed1f08484d53c6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET G1 FORTE ", "description": "SEIZMET G1 FORTE \nGlimepiride (1mg), Metformin (1000mg)\nIntroduction to SEIZMET G1 FORTE\nSEIZMET G1 FORTE is a combination medication that includes Glimepiride 1mg and Metformin Hydrochloride 1000mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride and Metformin, SEIZMET G1 FORTE offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride and Metformin?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization, making it an effective treatment for type 2 diabetes.\n\nBenefits of SEIZMET G1 FORTE\nEffective Blood Sugar Management\nInsulin Secretion and Sensitivity: Glimepiride stimulates insulin secretion from the pancreas, while Metformin improves insulin sensitivity and reduces hepatic glucose production, providing a dual mechanism of action for comprehensive glycemic control.\nPostprandial and Fasting Glucose Control: Glimepiride helps manage postprandial (after-meal) glucose levels, while Metformin assists in controlling both fasting and postprandial blood sugar levels.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET G1 FORTE is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET G1 FORTE can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nCardiovascular Benefits: Metformin has beneficial effects on cardiovascular health, reducing the risk of heart disease and stroke in patients with type 2 diabetes.\nHow to Use SEIZMET G1 FORTE\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET G1 FORTE is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET G1 FORTE regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-g1-forte-133438", "price": 115.24, "discountamount": 34.57, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Diet", "body", "liver", "EMAIL", "Order", "meals", "water", "action", "option", "amount", "stroke", "Support", "Overview", "pancreas", "readings", "biguanide", "full glass", "neuropathy", "Guidelines", "overweight", "one tablet", "Adjustments", "information", "utilization", "Optimal Use", "retinopathy", "best results", "Reduced Risk", "sulfonylurea", "sterisonline", "instructions", "sterispharma", "Introduction", "heart disease", "effectiveness", "CALL/WHATSAPP", "Consistent Use", "treatment plan", "Administration", "typical dosage", "dual mechanism", "obese patients", "Glimepiride 1mg", "Exercise Adjunct", "SEIZMET G1 FORTE", "Weight Management", "insulin secretion", "weight neutrality", "excellent adjunct", "Recommended Dosage", "modest weight loss", "beneficial effects", "insulin sensitivity", "blood sugar control", "individual response", "healthcare provider", "effective treatment", "Diabetes Management", "meal) glucose levels", "cardiovascular health", "pancreatic beta cells", "cardiovascular disease", "combination medication", "Fasting Glucose Control", "Cardiovascular Benefits", "long-term complications", "lifestyle modifications", "Metformin Hydrochloride", "type 2 diabetes mellitus", "complementary mechanisms", "peripheral glucose uptake", "stable blood sugar levels", "Additional Health Benefits", "hepatic glucose production", "gastrointestinal discomfort", "comprehensive glycemic control", "postprandial blood sugar levels", "ATP-sensitive potassium channels", "Effective Blood Sugar Management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1429, "imageuri": "https://productimages.withfloats.com/actual/666174c94b2b24fcd89d3e94.png", "tileimageuri": "https://productimages.withfloats.com/tile/666174c94b2b24fcd89d3e94.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T08:35:18.706Z", "updatedon": "2026-03-13T06:10:33.25Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//seizmet-g1-forte-/1429", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET G1 FORTE ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET G1 FORTE", "Glimepiride (1mg)", "Metformin (1000mg)", "Metformin 1000mg uses", "Metformin 1000mg side effects", "Metformin 1000 mg price", "Metformin hydrochloride 500 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665ef7cfea22b014e8aefff9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLICLAGLAZE MR 30 ", "description": "GLICLAGLAZE MR 30 \ngliclazide sr (30 mg)\nIntroduction\nGLICLAGLAZE MR 30 is specifically formulated for individuals managing Type 2 diabetes. This medication utilizes a sustained release (SR) form of Gliclazide at a 30 mg dosage, focusing on providing a steady, controlled release of the drug to maintain optimal blood sugar levels throughout the day.\n\nHow It Works\n\nGliclazide SR (30 mg): Gliclazide is a sulfonylurea class drug that increases insulin secretion from the pancreas. Unlike standard formulations, the SR version releases the medication gradually, which helps to stabilize blood sugar levels and reduces the risk of severe fluctuations that can lead to hypoglycemia. This mechanism not only enhances the body’s natural insulin use but also supports overall vascular health, decreasing the risk of complications associated with diabetes, such as cardiovascular disease.\nBenefits\nGLICLAGLAZE MR 30 is an excellent choice for patients who require a mild enhancement in their insulin secretion with a lower risk of hypoglycemia. The SR formulation provides a more predictable pharmacokinetic profile, which is crucial for maintaining a stable glycemic control. This can significantly improve the quality of life for patients by reducing common side effects associated with blood sugar spikes and drops.\n\nDosage and Administration\n\nDosage: The dose of GLICLAGLAZE MR 30 should be adjusted based on the patient’s blood glucose response and previous treatment history. Regular monitoring of blood glucose and glycated hemoglobin (HbA1c) levels is recommended to ensure that the dosage is effective.\nAdministration: This medication should be taken with breakfast or the first main meal of the day. The tablet should be swallowed whole to maintain the integrity of the sustained release mechanism.\nSide Effects\nPossible side effects of GLICLAGLAZE MR 30 include gastrointestinal issues such as nausea and upset stomach. Due to its sulfonylurea component, there is a risk of hypoglycemia, although it is generally lower compared to other sulfonylureas due to the sustained release formulation.\n\nConclusion\nGLICLAGLAZE MR 30 is a practical and effective solution for managing Type 2 diabetes, especially suited for patients seeking a gentle modification in their diabetes treatment plan with sustained drug release. It simplifies diabetes management, potentially enhancing adherence and minimizing the risk of dosage-related complications. As with any medication, consultation with a healthcare provider is essential to tailor the treatment to individual needs and conditions.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/gliclaglaze-mr-30-133422", "price": 83.0, "discountamount": 24.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "dose", "life", "body", "drops", "EMAIL", "Order", "upset", "tablet", "nausea", "stomach", "quality", "SR) form", "patients", "Benefits", "pancreas", "adherence", "integrity", "breakfast", "practical", "lower risk", "SR version", "medication", "conditions", "Conclusion", "individuals", "information", "sterisonline", "Introduction", "30 mg dosage", "consultation", "sterispharma", "hypoglycemia", "CALL/WHATSAPP", "Gliclazide SR", "HbA1c) levels", "SR formulation", "GLICLAGLAZE MR", "first main meal", "Type 2 diabetes", "mild enhancement", "individual needs", "excellent choice", "insulin secretion", "effective solution", "Regular monitoring", "blood sugar spikes", "healthcare provider", "diabetes management", "gentle modification", "other sulfonylureas", "common side effects", "glycated hemoglobin", "severe fluctuations", "natural insulin use", "Possible side effects", "standard formulations", "Administration Dosage", "sulfonylurea component", "sustained drug release", "blood glucose response", "cardiovascular disease", "diabetes treatment plan", "stable glycemic control", "gastrointestinal issues", "overall vascular health", "sulfonylurea class drug", "steady, controlled release", "optimal blood sugar levels", "previous treatment history", "sustained release mechanism", "dosage-related complications", "sustained release formulation", "predictable pharmacokinetic profile" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1291, "imageuri": "https://productimages.withfloats.com/actual/665ef7d253245b8b6b459895.png", "tileimageuri": "https://productimages.withfloats.com/tile/665ef7d253245b8b6b459895.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T11:17:35.736Z", "updatedon": "2024-06-04T11:17:35.736Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//gliclaglaze-mr-30-/1291", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLICLAGLAZE MR 30 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "665dbb06dce9381dfcc553b6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DAPA VILDA 10/100 SR ", "description": "DAPA VILDA 10/100 SR \nDapagliflozin (10mg), Vildagliptin SR (100mg)\nIntroduction to DAPA VILDA 10/100 SR\nDAPA VILDA 10/100 SR is a combination medication that includes Dapagliflozin 10mg and Vildagliptin 100mg in a sustained-release (SR) formulation. This medication is primarily used for the management of type 2 diabetes mellitus. Dapagliflozin and Vildagliptin work together to improve blood sugar control through complementary mechanisms, making this combination an effective treatment option for patients needing comprehensive glycemic management.\n\nWhat are Dapagliflozin and Vildagliptin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood. Instead, it allows glucose to be excreted in the urine, thereby lowering blood glucose levels.\n\nOverview of Vildagliptin\nVildagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that enhances the body's natural incretin hormones, which help regulate blood glucose by increasing insulin release and decreasing glucagon levels in response to meals. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of DAPA VILDA 10/100 SR\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Vildagliptin helps regulate postprandial (after-meal) glucose levels, while Dapagliflozin assists in lowering fasting glucose levels by promoting glucose excretion through urine.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nWeight Management and Cardiovascular Benefits\nWeight Reduction: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nConvenience and Compliance\nOnce-Daily Dosing: The sustained-release formulation of Vildagliptin allows for once-daily dosing, improving patient compliance and convenience.\nReduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use DAPA VILDA 10/100 SR\nDosage and Administration\nRecommended Dosage: The typical dosage of DAPA VILDA 10/100 SR is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food, preferably at the same time each day to maintain consistent blood levels of the medication. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take DAPA VILDA 10/100 SR regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/dapa-vilda-10-100-sr-134064", "price": 210.0, "discountamount": 63.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "food", "risk", "urine", "EMAIL", "Order", "meals", "water", "action", "kidneys", "one pill", "calories", "readings", "Overview", "same time", "full glass", "Guidelines", "one tablet", "Optimal Use", "Adjustments", "information", "weight loss", "Convenience", "Introduction", "Daily Dosing", "best results", "sterisonline", "sterispharma", "Postprandial", "CALL/WHATSAPP", "heart failure", "treatment plan", "Administration", "typical dosage", "dual mechanism", "Consistent Use", "sodium-glucose", "glucagon levels", "two medications", "insulin release", "Vildagliptin SR", "Weight Reduction", "prolonged effect", "SGLT2 inhibitors", "diabetic patients", "treatment regimen", "Weight Management", "glucose excretion", "multiple pathways", "Dapagliflozin 10mg", "prescribed therapy", "patient compliance", "blood sugar levels", "glucose regulation", "Recommended Dosage", "individual response", "blood sugar control", "healthcare provider", "Reduced Pill Burden", "meal) glucose levels", "blood glucose levels", "DAPA VILDA 10/100 SR", "combination medication", "Fasting Glucose Control", "consistent blood levels", "Cardiovascular Benefits", "transporter-2) inhibitor", "complementary mechanisms", "type 2 diabetes mellitus", "natural incretin hormones", "Cardiovascular Protection", "effective treatment option", "other cardiovascular events", "sustained-release formulation", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "comprehensive glycemic management", "dipeptidyl peptidase-4) inhibitor", "sustained-release (SR) formulation", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1253, "imageuri": "https://productimages.withfloats.com/actual/665dbb093b5550f17788eb4e.png", "tileimageuri": "https://productimages.withfloats.com/tile/665dbb093b5550f17788eb4e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-03T12:45:58.06Z", "updatedon": "2026-03-13T06:56:35.011Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dapa-vilda-10-100-sr-/1253", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DAPA VILDA 10/100 SR ", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }